Cargando…
Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning
Interpretable risk assessment of SARS-CoV-2 positive patients can aid clinicians to implement precision medicine. Here we trained a machine learning model to predict mortality within 12 weeks of a first positive SARS-CoV-2 test. By leveraging data on 33,938 confirmed SARS-CoV-2 cases in eastern Denm...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380679/ https://www.ncbi.nlm.nih.gov/pubmed/35974050 http://dx.doi.org/10.1038/s41598-022-17953-y |
_version_ | 1784768925378019328 |
---|---|
author | Zucco, Adrian G. Agius, Rudi Svanberg, Rebecka Moestrup, Kasper S. Marandi, Ramtin Z. MacPherson, Cameron Ross Lundgren, Jens Ostrowski, Sisse R. Niemann, Carsten U. |
author_facet | Zucco, Adrian G. Agius, Rudi Svanberg, Rebecka Moestrup, Kasper S. Marandi, Ramtin Z. MacPherson, Cameron Ross Lundgren, Jens Ostrowski, Sisse R. Niemann, Carsten U. |
author_sort | Zucco, Adrian G. |
collection | PubMed |
description | Interpretable risk assessment of SARS-CoV-2 positive patients can aid clinicians to implement precision medicine. Here we trained a machine learning model to predict mortality within 12 weeks of a first positive SARS-CoV-2 test. By leveraging data on 33,938 confirmed SARS-CoV-2 cases in eastern Denmark, we considered 2723 variables extracted from electronic health records (EHR) including demographics, diagnoses, medications, laboratory test results and vital parameters. A discrete-time framework for survival modelling enabled us to predict personalized survival curves and explain individual risk factors. Performance on the test set was measured with a weighted concordance index of 0.95 and an area under the curve for precision-recall of 0.71. Age, sex, number of medications, previous hospitalizations and lymphocyte counts were identified as top mortality risk factors. Our explainable survival model developed on EHR data also revealed temporal dynamics of the 22 selected risk factors. Upon further validation, this model may allow direct reporting of personalized survival probabilities in routine care. |
format | Online Article Text |
id | pubmed-9380679 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-93806792022-08-17 Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning Zucco, Adrian G. Agius, Rudi Svanberg, Rebecka Moestrup, Kasper S. Marandi, Ramtin Z. MacPherson, Cameron Ross Lundgren, Jens Ostrowski, Sisse R. Niemann, Carsten U. Sci Rep Article Interpretable risk assessment of SARS-CoV-2 positive patients can aid clinicians to implement precision medicine. Here we trained a machine learning model to predict mortality within 12 weeks of a first positive SARS-CoV-2 test. By leveraging data on 33,938 confirmed SARS-CoV-2 cases in eastern Denmark, we considered 2723 variables extracted from electronic health records (EHR) including demographics, diagnoses, medications, laboratory test results and vital parameters. A discrete-time framework for survival modelling enabled us to predict personalized survival curves and explain individual risk factors. Performance on the test set was measured with a weighted concordance index of 0.95 and an area under the curve for precision-recall of 0.71. Age, sex, number of medications, previous hospitalizations and lymphocyte counts were identified as top mortality risk factors. Our explainable survival model developed on EHR data also revealed temporal dynamics of the 22 selected risk factors. Upon further validation, this model may allow direct reporting of personalized survival probabilities in routine care. Nature Publishing Group UK 2022-08-16 /pmc/articles/PMC9380679/ /pubmed/35974050 http://dx.doi.org/10.1038/s41598-022-17953-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Zucco, Adrian G. Agius, Rudi Svanberg, Rebecka Moestrup, Kasper S. Marandi, Ramtin Z. MacPherson, Cameron Ross Lundgren, Jens Ostrowski, Sisse R. Niemann, Carsten U. Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning |
title | Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning |
title_full | Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning |
title_fullStr | Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning |
title_full_unstemmed | Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning |
title_short | Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning |
title_sort | personalized survival probabilities for sars-cov-2 positive patients by explainable machine learning |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380679/ https://www.ncbi.nlm.nih.gov/pubmed/35974050 http://dx.doi.org/10.1038/s41598-022-17953-y |
work_keys_str_mv | AT zuccoadriang personalizedsurvivalprobabilitiesforsarscov2positivepatientsbyexplainablemachinelearning AT agiusrudi personalizedsurvivalprobabilitiesforsarscov2positivepatientsbyexplainablemachinelearning AT svanbergrebecka personalizedsurvivalprobabilitiesforsarscov2positivepatientsbyexplainablemachinelearning AT moestrupkaspers personalizedsurvivalprobabilitiesforsarscov2positivepatientsbyexplainablemachinelearning AT marandiramtinz personalizedsurvivalprobabilitiesforsarscov2positivepatientsbyexplainablemachinelearning AT macphersoncameronross personalizedsurvivalprobabilitiesforsarscov2positivepatientsbyexplainablemachinelearning AT lundgrenjens personalizedsurvivalprobabilitiesforsarscov2positivepatientsbyexplainablemachinelearning AT ostrowskisisser personalizedsurvivalprobabilitiesforsarscov2positivepatientsbyexplainablemachinelearning AT niemanncarstenu personalizedsurvivalprobabilitiesforsarscov2positivepatientsbyexplainablemachinelearning |